Requirements for Brazilian Outpatient Centers of Excellence in Hidradenitis Suppurativa: Consensus
Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
DOVE MEDICAL PRESS LTD
Autores
BELLEI, Ericles Andrei
SHIROZAKI, Miriam Emi Makinodan
PUGLIA, Ana Lia Pradella
CARVALHO, Andre Vicente Esteves de
VALLILO, Camilla Carlini
BARROS, Danilo de
TAMASHIRO, Erika Yumi
CINTRA, Gabriela
DUARTE, Gleison Vieira
Citação
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, v.16, p.2029-2044, 2023
Resumo
Background: Hidradenitis suppurativa (HS) is a chronic skin condition. Its complexity and impact on patients highlight the need for multidisciplinary care that can address the physical, psychological, and social aspects. Centers of excellence can ideally provide the necessary infrastructure, resources, and expertise to effectively treat HS. However, there are still no consolidated models of centers of excellence in HS, and establishing their foundations is an intricate research challenge. Purposely, design and co-creation as innovation techniques are helpful approaches to this type of research. Methods: In this study, we conducted a co-creation with consensus among HS specialists to propose the criteria and requirements to establish outpatient centers of excellence of HS in Brazil. We followed a linear process with mixed methods in 6 stages. Results: The process resulted in 10 categories for establishing outpatient centers, including their respective requirements, rationale, and classification. The categories include onboarding and welcoming; infrastructure and procedures; infusion therapy; flows and referrals; staffing; disease management; metrics during diagnosis; metrics during treatment; awareness and advocacy; research and education. Discussion: The idealized outpatient centers can play a role in the complete multidisciplinary treatment for HS and advancing the science of healthcare services by providing a focus for research, training, and translation of findings into practice.
Palavras-chave
hidradenitis suppurativa, centers of excellence, co -design, consensus, health services research, patient-centered care, community-based participatory research, healthcare innovation
Referências
- Alafaireet P., 2023, HUMAN CENTERED SERVI, P1
- Alikhan A, 2019, J AM ACAD DERMATOL, V81, P91, DOI 10.1016/j.jaad.2019.02.068
- Da Silva JLA, 2021, JMIR SERIOUS GAMES, V9, DOI 10.2196/23423
- Angastiniotis Michael, 2009, Hemoglobin, V33 Suppl 1, pS204, DOI 10.3109/03630260903351890
- Bird M, 2021, Res Involv Engagem, V7, P12, DOI 10.1186/s40900-021-00252-7
- Chernyshov PV, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116131
- Clack L, 2023, HUMAN CENTERED SERVI, P167
- Campos GWD, 2018, CIENC SAUDE COLETIVA, V23, P1707, DOI 10.1590/1413-81232018236.05582018
- Corrêa JE, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/1393585
- Elrod JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2340-y
- Faust J, 2023, HUMAN CENTERED SERVI, P197
- Glowaczewska A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10184194
- Goermar L, 2021, KNOWL MAN RES PRACT, V19, P53, DOI 10.1080/14778238.2020.1740627
- Greenfield D, 2008, INT J QUAL HEALTH C, V20, P172, DOI 10.1093/intqhc/mzn005
- Greenhalgh T, 2016, MILBANK Q, V94, P392, DOI 10.1111/1468-0009.12197
- Guest Greg, 2014, Applied thematic analysis, P3, DOI [DOI 10.4135/9781483384436, 10.4135/9781483384436]
- Ianhez M, 2018, INT J DERMATOL, V57, P618, DOI 10.1111/ijd.13937
- Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3
- Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]
- Lakshman M., 2000, Indian Journal of Pediatrics, V67, P358, DOI 10.1007/BF02820688
- Lam MB, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4011
- Magalhaes RF, 2019, AN BRAS DERMATOL, V94, pS7, DOI 10.1590/abd1806-4841.20198607
- Manyazewal T, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2021-050419
- Maurer M, 2016, ALLERGY, V71, P1210, DOI 10.1111/all.12901
- Mehrotra A, 2015, ANN SURG, V261, P237, DOI 10.1097/SLA.0000000000001071
- Montero-Vilchez T, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18136709
- Negreanu L, 2014, J GASTROINTEST LIVER, V23, P333, DOI [10.15403/jgld.2014.1121.233.ln1, 10.1543/jgld.2014.1121.233.ln1]
- Rezaie L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072514
- Ruggiero A, 2022, BIOMEDICINES, V10, DOI 10.3390/biomedicines10020455
- Sampogna F, 2021, J CLIN MED, V10, DOI 10.3390/jcm10163648
- Scala E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10082094
- Schiavone F, 2020, BUS PROCESS MANAG J, V26, P889, DOI 10.1108/BPMJ-11-2019-0475
- Shavit E, 2015, J EUR ACAD DERMATOL, V29, P371, DOI 10.1111/jdv.12567
- Shih Terri, 2023, JAAD Int, V11, P117, DOI 10.1016/j.jdin.2023.01.021
- Shih Terri, 2022, Int J Womens Dermatol, V8, pe040, DOI 10.1097/JW9.0000000000000040
- Siemon D., 2018, J. Creativity Bus. Innov., V4, P96
- Slattery P, 2020, HEALTH RES POLICY SY, V18, DOI 10.1186/s12961-020-0528-9
- Tarca E, 2021, J MULTIDISCIP HEALTH, V14, P2205, DOI 10.2147/JMDH.S324325
- Thorlacius L, 2018, BRIT J DERMATOL, V179, P642, DOI 10.1111/bjd.16672
- Thorlacius L, 2018, J INVEST DERMATOL, V138, P52, DOI 10.1016/j.jid.2017.09.008
- Toledo Isabella, 2022, JAAD Int, V6, P84, DOI 10.1016/j.jdin.2021.11.007
- van Dijk-de Vries A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240543
- van Straalen KR, 2022, EXP DERMATOL, V31, P33, DOI 10.1111/exd.14609
- Vangipuram R, 2016, DERMATOLOGY, V232, P692, DOI 10.1159/000453259
- Vargas C, 2022, PUBLIC HEALTH RES PR, V32, DOI 10.17061/phrp3222211
- World Health Organization World Bank Group OECD, 2018, DEL QUAL SERV GLOB I
- Zouboulis CC, 2015, J EUR ACAD DERMATOL, V29, P619, DOI 10.1111/jdv.12966